
Asimov provides scientists and manufacturers tools that simplify designing and manufacturing biologic drugs and gene therapies. The company combines mammalian synthetic biology with computer-aided…

Asimov provides scientists and manufacturers tools that simplify designing and manufacturing biologic drugs and gene therapies. The company combines mammalian synthetic biology with computer-aided…
Headquarters & focus: Boston-based synthetic biology company building CAD-style platform for biologic, cell, gene, and RNA therapeutic design
Product: Integrated platform of engineered host cell lines, validated genetic parts, and cloud-based design software (CHO Edge, LV Edge, AAV Edge, RNA Edge)
Founding: Founded in 2017 by Alec Nielsen, Christopher Voigt, Douglas Densmore, and Raja Srinivas
Funding: Reported total funding approximately $205M, including a reported $200M round announced Jan 2023
Employees: Approximately 106 employees
Design and manufacturing tooling for next-generation biologics, cell, gene, and RNA therapies.
2017
Biotechnology Research
4700000
Reported seed financing at company launch
200000000
Reported large institutional financing announced Jan 2023
“AME Cloud Ventures, Andreessen Horowitz, CPP Investments, Casdin Capital, DCVC, Fidelity, Horizons Ventures, KdT Ventures, Pillar VC”
| Company |
|---|
Our mission at Asimov is to advance humanity's ability to design living systems, enabling biotechnologies with outsized benefit to society. We're developing a mammalian synthetic biology platform––from cells to software––to enable the design and manufacture of next-generation therapeutics.
We are seeking a Scientist, Biologics Cell Line Development to join our team in Boston, MA and help push the boundaries of biotherapeutic cell line development. This role is for a technical expert who will conduct CHO-based cell line engineering for biologic therapeutics, design complex experimental approaches to improve our workflows and systems, coordinate project efforts, and mentor junior scientists.
The successful candidate will also work closely with Asimov’s synthetic biology and process development teams. This is a unique opportunity to work at a nimble, forward-thinking synthetic biology startup and help build the future of biological engineering.
We're fueled by a vision to transform biological engineering into a fully-fledged engineering discipline. Should you join our team, you will grow with a constantly evolving organization and push the frontiers of synthetic biology. Company culture is key to Asimov, and ours is a culture of recombination; we believe that our mission can only be achieved by bringing together a diverse team with a mixture of backgrounds and perspectives.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week